evenfolioETF Details
Franklin Templeton, Inc·Health·HELX · Cboe BZX
Franklin Genomic Advancements ETF (HELX)
- Price
- $44.30
- —25 Sept 2026
- Assets
- $31.5M
- Total net assets
- Expense ratio
- 0.50%
- Category 1.00%
- Yield
- 0.34%
- Trailing distributions
- 1Y return
- 49.0%+13.0%
- Category 36.0%
- 3Y CAGR
- 16.3%-0.2%
- Category 16.5%
- 5Y CAGR
- -4.6%-7.5%
- Category 2.9%
Loading NAV history…
Franklin Genomic Advancements ETF
Calendar-year returns
Fund only: no comparison series covers this fund's history.
Risk statistics
Five years of daily closes. Risk-free rate 4% a year.
- Standard deviation
- —
- Maximum drawdown
- —
- Sharpe ratio
- —
- Sortino ratio
- —
- Beta
- —
- Alpha
- —
- R²
- —
- Information ratio
- —
- Upside capture
- —
- Downside capture
- —
- Tracking error
- —
| Period | 1M | 3M | 6M | YTD | 1Y | 3YCAGR | 5YCAGR | 10YCAGR | LaunchCAGR |
|---|---|---|---|---|---|---|---|---|---|
| ETF | +2.0% | +12.4% | +41.8% | +22.0% | +49.0% | +16.3% | -4.6% | — | +9.9% |
| Health average | -3.2% | 5.9% | 25.6% | 16.1% | 36.0% | 16.5% | 2.9% | 9.1% | 11.4% |
| Difference | +5.3% | +6.5% | +16.2% | +5.9% | +13.0% | -0.2% | -7.5% | — | -1.5% |
Holdings
The 10 largest positions make up 48.5% of the fund.
Top holdings
| Ticker | Holding | Weight |
|---|---|---|
| GH | Guardant Health Inc | 9.14% |
| NTRA | Natera Inc | 8.40% |
| KRYS | Krystal Biotech Inc | 5.80% |
| ADPT | Adaptive Biotechnologies Corp | 4.40% |
| LGND | Ligand Pharmaceuticals Inc | 4.29% |
| TWST | Twist Bioscience Corp | 4.00% |
| BBIO | BridgeBio Pharma Inc | 3.42% |
| UTHR | United Therapeutics Corp | 3.14% |
| TVTX | Travere Therapeutics Inc Ordinary Shares | 3.04% |
| VRTX | Vertex Pharmaceuticals Inc | 2.86% |
Portfolio valuation
Weighted averages of what the fund holds.
- P/E
- —
- P/B
- 6.1
- P/S
- 9.5
- P/CF
- 27.0
Sector allocation
Share of the equity the fund holds.
- Health care96.5%
- Materials2.6%
- Technology0.8%
Asset mix
- Stocks100.0%
- Cash0.0%
ETF details
- Issuer
- Franklin Templeton, Inc
- Category
- Equity · Health
- Ticker
- HELX
- Exchange
- Cboe BZX
- Inception
- 25 Feb 2020 (6.6 years)
- Structure
- Exchange Traded Fund
- Expense ratio
- 0.50% (category 1.00%)
- Holdings turnover
- 29% (category 51%)
- Distribution yield
- 0.34%
- Beta, 3 years
- 1.02
- Total net assets
- $31.5M
Prices and returns as of 25 Sept 2026; total return with distributions reinvested, before brokerage and taxes. Not investment advice.
Other health ETFs
Other ETFs in the Health category.
- HEAL · Global X HealthTech ETFGlobal X Funds · $31.2M · ER 0.50%5Y -11.7%
- GDOC · Future Health Care Equity ETFGoldman Sachs · $19.6M · ER 0.75%
- MEDX · Horizon Kinetics Medical ETFHorizon Kinetics · $17.1M · ER 0.85%
- JDOC · JPMorgan Healthcare Leaders ETFJPMorgan · $9.4M · ER 0.65%
- IBRN · iShares Neuroscience and Healthcare ETFiShares · $7.8M · ER 0.47%
- HLTH · Tema Healthcare AI ETFTema ETFs · $7.7M